ID   DUS11_HUMAN             Reviewed;         330 AA.
AC   O75319; B2RCT8; Q6AI47; Q9BWE3;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   15-MAR-2017, entry version 143.
DE   RecName: Full=RNA/RNP complex-1-interacting phosphatase;
DE            EC=3.1.3.-;
DE   AltName: Full=Dual specificity protein phosphatase 11;
DE   AltName: Full=Phosphatase that interacts with RNA/RNP complex 1;
GN   Name=DUSP11; Synonyms=PIR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   SFRS7 AND SFRS9, MUTAGENESIS OF CYS-152, ACTIVE SITE, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9685386; DOI=10.1074/jbc.273.32.20347;
RA   Yuan Y., Li D.-M., Sun H.;
RT   "PIR1, a novel phosphatase that exhibits high affinity to RNA
RT   ribonucleoprotein complexes.";
RL   J. Biol. Chem. 273:20347-20353(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHARACTERIZATION, MUTAGENESIS OF CYS-152, AND FUNCTION.
RX   PubMed=10347225; DOI=10.1074/jbc.274.23.16590;
RA   Deshpande T., Takagi T., Hao L., Buratowski S., Charbonneau H.;
RT   "Human PIR1 of the protein-tyrosine phosphatase superfamily has RNA
RT   5'-triphosphatase and diphosphatase activities.";
RL   J. Biol. Chem. 274:16590-16594(1999).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.38 ANGSTROMS) OF 28-208 IN COMPLEX WITH THE
RP   SUBSTRATE ANALOG PHOSPHATE, AND SUBUNIT.
RX   PubMed=24531476; DOI=10.1107/S1399004713029866;
RA   Jeong D.G., Wei C.H., Ku B., Jeon T.J., Chien P.N., Kim J.K.,
RA   Park S.Y., Hwang H.S., Ryu S.Y., Park H., Kim D.S., Kim S.J.,
RA   Ryu S.E.;
RT   "The family-wide structure and function of human dual-specificity
RT   protein phosphatases.";
RL   Acta Crystallogr. D 70:421-435(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.20 ANGSTROMS) OF 29-205 OF MUTANT SER-152 IN
RP   COMPLEX WITH PHOSPHATE, MUTAGENESIS OF HIS-119; CYS-152; HIS-154;
RP   ASN-157 AND ARG-192, ACTIVE SITE, AND FUNCTION.
RX   PubMed=24447265; DOI=10.1021/bi401240x;
RA   Sankhala R.S., Lokareddy R.K., Cingolani G.;
RT   "Structure of human PIR1, an atypical dual-specificity phosphatase.";
RL   Biochemistry 53:862-871(2014).
CC   -!- FUNCTION: Possesses RNA 5'-triphosphatase and diphosphatase
CC       activities, but displays a poor protein-tyrosine phosphatase
CC       activity. In addition, has phosphatase activity with ATP, ADP and
CC       O-methylfluorescein phosphate (in vitro). Binds to RNA. May
CC       participate in nuclear mRNA metabolism.
CC       {ECO:0000269|PubMed:10347225, ECO:0000269|PubMed:24447265,
CC       ECO:0000269|PubMed:9685386}.
CC   -!- SUBUNIT: Monomer (PubMed:24531476). May interact with SFRS7 and
CC       SFRS9/SRP30C (PubMed:24447265). {ECO:0000269|PubMed:24447265,
CC       ECO:0000269|PubMed:24531476}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9685386}.
CC       Nucleus speckle {ECO:0000269|PubMed:9685386}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75319-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75319-2; Sequence=VSP_014136, VSP_014137;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class dual specificity subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH10467.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF023917; AAC39925.1; -; mRNA.
DR   EMBL; AK315271; BAG37685.1; -; mRNA.
DR   EMBL; CR627368; CAH10467.1; ALT_INIT; mRNA.
DR   EMBL; AC092653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000346; AAH00346.1; -; mRNA.
DR   RefSeq; NP_003575.2; NM_003584.2.
DR   UniGene; Hs.14611; -.
DR   PDB; 4JMJ; X-ray; 2.38 A; A=28-208.
DR   PDB; 4MBB; X-ray; 1.85 A; A=29-207.
DR   PDB; 4NYH; X-ray; 1.20 A; A/B/C=29-205.
DR   PDBsum; 4JMJ; -.
DR   PDBsum; 4MBB; -.
DR   PDBsum; 4NYH; -.
DR   ProteinModelPortal; O75319; -.
DR   SMR; O75319; -.
DR   BioGrid; 114024; 23.
DR   IntAct; O75319; 5.
DR   MINT; MINT-1401557; -.
DR   STRING; 9606.ENSP00000272444; -.
DR   DEPOD; O75319; -.
DR   iPTMnet; O75319; -.
DR   PhosphoSitePlus; O75319; -.
DR   BioMuta; DUSP11; -.
DR   EPD; O75319; -.
DR   MaxQB; O75319; -.
DR   PaxDb; O75319; -.
DR   PeptideAtlas; O75319; -.
DR   PRIDE; O75319; -.
DR   DNASU; 8446; -.
DR   Ensembl; ENST00000272444; ENSP00000272444; ENSG00000144048.
DR   GeneID; 8446; -.
DR   KEGG; hsa:8446; -.
DR   UCSC; uc002sjp.4; human. [O75319-1]
DR   CTD; 8446; -.
DR   DisGeNET; 8446; -.
DR   GeneCards; DUSP11; -.
DR   H-InvDB; HIX0017827; -.
DR   HGNC; HGNC:3066; DUSP11.
DR   HPA; HPA021052; -.
DR   MIM; 603092; gene.
DR   neXtProt; NX_O75319; -.
DR   PharmGKB; PA27521; -.
DR   eggNOG; KOG2386; Eukaryota.
DR   eggNOG; COG5226; LUCA.
DR   HOGENOM; HOG000112295; -.
DR   HOVERGEN; HBG051420; -.
DR   InParanoid; O75319; -.
DR   KO; K14165; -.
DR   OrthoDB; EOG091G0HD0; -.
DR   PhylomeDB; O75319; -.
DR   TreeFam; TF105124; -.
DR   ChiTaRS; DUSP11; human.
DR   GenomeRNAi; 8446; -.
DR   PRO; PR:O75319; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000144048; -.
DR   CleanEx; HS_DUSP11; -.
DR   ExpressionAtlas; O75319; baseline and differential.
DR   Genevisible; O75319; HS.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0045171; C:intercellular bridge; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0098519; F:nucleotide phosphatase activity, acting on free nucleotides; IMP:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004651; F:polynucleotide 5'-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0098507; P:polynucleotide 5' dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0016070; P:RNA metabolic process; IDA:UniProtKB.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Hydrolase;
KW   Nucleus; Reference proteome; RNA-binding.
FT   CHAIN         1    330       RNA/RNP complex-1-interacting
FT                                phosphatase.
FT                                /FTId=PRO_0000094816.
FT   DOMAIN      128    197       Tyrosine-protein phosphatase.
FT   REGION      153    158       Substrate binding.
FT                                {ECO:0000305|PubMed:24531476}.
FT   ACT_SITE    152    152       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044,
FT                                ECO:0000269|PubMed:24447265,
FT                                ECO:0000305|PubMed:9685386}.
FT   ACT_SITE    158    158       Proton donor/acceptor. {ECO:0000255}.
FT   VAR_SEQ     166    226       YLIDVEGVRPDDAIELFNRCRGHCLERQNYIEDLQNGPIRK
FT                                NWNSSVPRSSDFEDSAHLMQ -> RSRALSPRLECSGTIST
FT                                HSKFCFPSSRRSPASASQVAGTTGARHHARLIFCIFSRDVV
FT                                SPC (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_014136.
FT   VAR_SEQ     227    330       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_014137.
FT   MUTAGEN     119    119       H->G: No effect on phosphatase activity
FT                                with ATP and ADP.
FT                                {ECO:0000269|PubMed:24447265}.
FT   MUTAGEN     152    152       C->S: Loss of activity. No effect in RNA-
FT                                binding. {ECO:0000269|PubMed:10347225,
FT                                ECO:0000269|PubMed:24447265,
FT                                ECO:0000269|PubMed:9685386}.
FT   MUTAGEN     154    154       H->A: Strongly decreases phosphatase
FT                                activity with ATP and ADP.
FT                                {ECO:0000269|PubMed:24447265}.
FT   MUTAGEN     157    157       N->A: Strongly decreases phosphatase
FT                                activity with ATP and ADP.
FT                                {ECO:0000269|PubMed:24447265}.
FT   MUTAGEN     192    192       R->K: Slightly decreases phosphatase
FT                                activity with ATP. Strongly decreases
FT                                phosphatase activity with ADP.
FT                                {ECO:0000269|PubMed:24447265}.
FT   CONFLICT    165    165       R -> I (in Ref. 5; AAH00346).
FT                                {ECO:0000305}.
FT   HELIX        35     37       {ECO:0000244|PDB:4NYH}.
FT   STRAND       48     53       {ECO:0000244|PDB:4NYH}.
FT   HELIX        59     64       {ECO:0000244|PDB:4NYH}.
FT   HELIX        67     69       {ECO:0000244|PDB:4NYH}.
FT   HELIX        73     82       {ECO:0000244|PDB:4NYH}.
FT   STRAND       87     92       {ECO:0000244|PDB:4NYH}.
FT   HELIX       102    104       {ECO:0000244|PDB:4NYH}.
FT   STRAND      111    113       {ECO:0000244|PDB:4NYH}.
FT   STRAND      118    120       {ECO:0000244|PDB:4NYH}.
FT   HELIX       124    139       {ECO:0000244|PDB:4NYH}.
FT   STRAND      147    151       {ECO:0000244|PDB:4NYH}.
FT   STRAND      153    156       {ECO:0000244|PDB:4NYH}.
FT   HELIX       157    171       {ECO:0000244|PDB:4NYH}.
FT   HELIX       175    186       {ECO:0000244|PDB:4NYH}.
FT   HELIX       193    201       {ECO:0000244|PDB:4NYH}.
SQ   SEQUENCE   330 AA;  38939 MW;  0C397F43043B450A CRC64;
     MSQWHHPRSG WGRRRDFSGR SSAKKKGGNH IPERWKDYLP VGQRMPGTRF IAFKVPLQKS
     FEKKLAPEEC FSPLDLFNKI REQNEELGLI IDLTYTQRYY KPEDLPETVP YLKIFTVGHQ
     VPDDETIFKF KHAVNGFLKE NKDNDKLIGV HCTHGLNRTG YLICRYLIDV EGVRPDDAIE
     LFNRCRGHCL ERQNYIEDLQ NGPIRKNWNS SVPRSSDFED SAHLMQPVHN KPVKQGPRYN
     LHQIQGHSAP RHFHTQTQSL QQSVRKFSEN PHVYQRHHLP PPGPPGEDYS HRRYSWNVKP
     NASRAAQDRR RWYPYNYSRL SYPACWEWTQ
//
